Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kruithof AC"'
Autor:
Prins MLM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Roozen GVT; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Pothast CR; Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands., Huisman W; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., van Binnendijk R; Department of Immune Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., den Hartog G; Department of Immune Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Laboratory of Medical Immunology, RadboudUMC, Nijmegen, The Netherlands., Kuiper VP; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Prins C; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Janse JJ; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Lamers OAC; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Koopman JPR; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Kruithof AC; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.; Center for Human Drug Research, Leiden, The Netherlands., Kamerling IMC; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.; Center for Human Drug Research, Leiden, The Netherlands., Dijkland RC; Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands., de Kroon AC; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Azimi S; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Feltkamp MCW; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., Kuijer M; Department of Immune Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Jochems SP; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Heemskerk MHM; Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands., Rosendaal FR; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands., Roestenberg M; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Visser LG; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Roukens AHE; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands. a.h.e.roukens@lumc.nl.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2024 Jan 02; Vol. 9 (1), pp. 1. Date of Electronic Publication: 2024 Jan 02.
Autor:
Bolognani F; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.) federico.bolognani@vectivbio.com., Kruithof AC; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.)., Schulthess P; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.)., Machacek M; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.)., de Kam ML; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.)., Bergmann KR; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.)., van Gent M; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.)., Moerland M; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.)., Crenn P; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.)., Greig G; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.)., Gal P; VectivBio AG, Basel, Switzerland (F.B.); Centre for Human Drug Research, Leiden, Netherlands (A.C.K., M.L.d.K., K.R.B., M.v.G., M.Mo., P.G.); LYO-X AG, Basel, Switzerland (P.S., M.Ma.); Leiden University Medical Center, Leiden, Netherlands (A.C.K., M.Mo., P.G.); University Paris-Saclay/APHP, Hospital Ambroise Pare, Nutrition Clinique, Boulogne-Billancourt, France (P.C.); and GreigG Consulting, Basel, Switzerland (G.G.).
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2023 Aug; Vol. 386 (2), pp. 129-137. Date of Electronic Publication: 2023 Jun 14.
Autor:
den Heijer JM; Department of Neurology, Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Centre, Leiden, the Netherlands., Kruithof AC; Department of Neurology, Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Centre, Leiden, the Netherlands., Moerland M; Department of Neurology, Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Centre, Leiden, the Netherlands., Walker M; Certara, QSP, Canterbury, United Kingdom., Dudgeon L; Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA., Justman C; Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA., Solomini I; Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA., Splitalny L; Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA., Leymarie N; Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA., Khatri K; Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA., Cullen VC; Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA., Hilt DC; Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA., Groeneveld GJ; Department of Neurology, Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Centre, Leiden, the Netherlands., Lansbury P; Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA.; Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2023 Jul; Vol. 38 (7), pp. 1197-1208. Date of Electronic Publication: 2023 May 17.
Autor:
Roozen GVT; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., Prins MLM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., van Binnendijk R; Department of Immune Surveillance, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., den Hartog G; Department of Immune Surveillance, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Kuiper VP; Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands., Prins C; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., Janse JJ; Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands., Kruithof AC; Department of Infectious Diseases, Leiden University Medical Center, and Centre for Human Drug Research, Leiden, the Netherlands., Feltkamp MCW; Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands., Kuijer M; Department of Immune Surveillance, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Rosendaal FR; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands., Roestenberg M; Department of Infectious Diseases and Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands., Visser LG; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., Roukens AHE; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
Publikováno v:
Annals of internal medicine [Ann Intern Med] 2022 Dec; Vol. 175 (12), pp. 1771-1774. Date of Electronic Publication: 2022 Oct 25.
Autor:
den Heijer JM; Clinical Pharmacology, Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology, Leiden University Medical Center, Leiden, The Netherlands., Heuberger JAAC; Clinical Pharmacology, Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology, Leiden University Medical Center, Leiden, The Netherlands., Hijma H; Clinical Pharmacology, Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology, Leiden University Medical Center, Leiden, The Netherlands., Kruithof AC; Clinical Pharmacology, Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology, Leiden University Medical Center, Leiden, The Netherlands., van Smeden J; Clinical Pharmacology, Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology, Leiden University Medical Center, Leiden, The Netherlands., Groeneveld GJ; Clinical Pharmacology, Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology, Leiden University Medical Center, Leiden, The Netherlands., Burggraaf J; Clinical Pharmacology, Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology, Leiden University Medical Center, Leiden, The Netherlands., Cohen A; Clinical Pharmacology, Centre for Human Drug Research, Leiden, The Netherlands.; Clinical Pharmacology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Dec; Vol. 87 (12), pp. 4552-4559. Date of Electronic Publication: 2021 May 03.
Autor:
den Heijer JM; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Kruithof AC; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., van Amerongen G; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., de Kam ML; Centre for Human Drug Research, Leiden, The Netherlands., Thijssen E; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Grievink HW; Centre for Human Drug Research, Leiden, The Netherlands., Moerland M; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Walker M; Certara, QSP, Canterbury, CT2 7FG, UK., Been K; Lysosomal Therapeutics Inc., Cambridge, MA, USA., Skerlj R; Lysosomal Therapeutics Inc., Cambridge, MA, USA., Justman C; Lysosomal Therapeutics Inc., Cambridge, MA, USA., Dudgeon L; Lysosomal Therapeutics Inc., Cambridge, MA, USA., Lansbury P; Lysosomal Therapeutics Inc., Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Cullen VC; Lysosomal Therapeutics Inc., Cambridge, MA, USA., Hilt DC; Lysosomal Therapeutics Inc., Cambridge, MA, USA., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Sep; Vol. 87 (9), pp. 3561-3573. Date of Electronic Publication: 2021 Mar 02.
Publikováno v:
International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2021 Feb; Vol. 59 (2), pp. 89-98.
Autor:
Goulooze SC; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden Academic Centre for Drug Research, Division of Systems Biomedicine and Pharmacology, Leiden University, Leiden, the Netherlands., Kruithof AC; Leiden University, Leiden University Medical Center, Leiden, the Netherlands., Alikunju S; Dr Reddy's Laboratories Ltd, Hyderabad, India., Gautam A; Dr Reddy's Laboratories SA, Basel, Switzerland., Burggraaf J; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden Academic Centre for Drug Research, Division of Systems Biomedicine and Pharmacology, Leiden University, Leiden, the Netherlands.; Leiden University, Leiden University Medical Center, Leiden, the Netherlands., Kamerling IMC; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University, Leiden University Medical Center, Leiden, the Netherlands., Stevens J; Centre for Human Drug Research, Leiden, the Netherlands.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2020 Oct; Vol. 86 (10), pp. 2095-2101. Date of Electronic Publication: 2020 Apr 20.
Publikováno v:
International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2020 Jul; Vol. 58 (7), pp. 395-403.
Autor:
Kruithof AC; Centre for Human Drug Research, Leiden, The Netherlands., Kumar R; Dr. Reddy's Laboratories Ltd, Hyderabad, India., Stevens J; Centre for Human Drug Research, Leiden, The Netherlands., de Kam ML; Centre for Human Drug Research, Leiden, The Netherlands., Gautam A; Dr. Reddy's Laboratories SA, Basel, Switzerland., Alikunju S; Dr. Reddy's Laboratories Ltd, Hyderabad, India., Padhi BK; Dr. Reddy's Laboratories Ltd, Hyderabad, India., Kulkarni S; Dr. Reddy's Laboratories Ltd, Hyderabad, India., Raghuvanshi RS; Dr. Reddy's Laboratories Ltd, Hyderabad, India., Gandhi R; Dr. Reddy's Laboratories Ltd, Hyderabad, India., Burggraaf J; Centre for Human Drug Research, Leiden, The Netherlands., Kamerling IMC; Centre for Human Drug Research, Leiden, The Netherlands.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Nov; Vol. 8 (8), pp. 1042-1052. Date of Electronic Publication: 2019 Jun 10.